Research Topics
| Paul E FarmerSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experienceSerena P Koenig
Harvard Medical School, Brigham and Women s Hospital, Boston, MA, USA
AIDS 18:S21-5. 2004....
Can transnational research be ethical in the developing world?Paul Farmer
Harvard Medical School and Partners In Health, Boston, MA 02115, USA
Lancet 360:1266. 2002
Structural violence and clinical medicinePaul E Farmer
Department of Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
PLoS Med 3:e449. 2006
Surgery and global health: a view from beyond the ORPaul E Farmer
Program in Infectious Disease and Social Change, Department of Social Medicine, Harvard Medical School, 641 Huntington Avenue, Boston, Massachusetts 02115, USA
World J Surg 32:533-6. 2008
Global health equityPaul E Farmer
Harvard Medical School, Boston, MA 02115, USA
Lancet 363:1832. 2004
Rethinking medical ethics: a view from belowPaul Farmer
Program in Infectious Disease and Social Change, 641 Huntington Avenue Boston, MA 02115 USA
Dev World Bioeth 4:17-41. 2004..We conclude that medical ethics must grapple more persistently with the growing problem posed by the yawning 'outcome gap' between rich and poor...
Unjust embargo of aid for HaitiPaul Farmer
Zanmi Lasante, Cange, Haiti
Lancet 361:420-3. 2003
An information system and medical record to support HIV treatment in rural HaitiHamish S F Fraser
Brigham and Women's Hospital, Division of Social Medicine and Healthcare Inequalities, 75 Francis Street, Boston, MA 02115, USA
BMJ 329:1142-6. 2004
Increasing access to surgical services for the poor in rural Haiti: surgery as a public good for public healthLouise C Ivers
Division of Social Medicine and Health Inequalities, Department of Medicine, Brigham and Women s Hospital, 641 Huntington Avenue, Boston, MA 02115, USA
World J Surg 32:537-42. 2008..There are numerous training, funding, and programmatic considerations, several of which are raised by considering the data from Haiti presented here...
Global AIDS: new challenges for health and human rightsPaul Farmer
The Maud and Lilian Presley Professor of Social Medicine, Department of Social Medicine, Harvard Medical School, 641 Huntington Avenue, Boston, MA 02115, USA
Perspect Biol Med 48:10-6. 2005
Monitoring HIV treatment in developing countriesSerena P Koenig
Division of Social Medicine and Health Inequalities, Brigham and Women's Hospital, 1620 Tremont Street, Boston, MA 02120, USA
BMJ 332:602-4. 2006
Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern AfricaKwonjune J Seung
Division of Global Health Equity, Brigham and Women s Hospital, Boston, Massachusetts, United States of America
PLoS ONE 4:e7186. 2009..Little is known about treatment of multidrug-resistant tuberculosis (MDR-TB) in high HIV-prevalence settings such as sub-Saharan Africa...
Poverty, global health, and infectious disease: lessons from Haiti and RwandaMarcella M Alsan
Division of Infectious Diseases, Department of Economics, Brigham and Women s Hospital, Harvard University, 75 Francis Street, Boston, MA 02115, USA
Infect Dis Clin North Am 25:611-22, ix. 2011....
Improving quality in resource poor settings: observational study from rural RwandaMeera Kotagal
Partners In Health, 888 Commonwealth Avenue, Third Floor, Boston, MA 02215, USA
BMJ 339:b3488. 2009..In our setting, basic care processes, such monitoring vital signs, giving drugs, and laboratory testing, were performed unreliably, resulting in delays in treatment owing to lack of information needed for clinical decision making...
High human immunodeficiency virus-free survival of infants born to human immunodeficiency virus-positive mothers in an integrated program to decrease child mortality in rural RwandaMolly F Franke
Partner In Health Inshuti Mu Buzima, Rwinkwavu, Rwanda
Pediatr Infect Dis J 30:614-6. 2011..The cumulative 12-month infant survival probability was 0.97 (95% confidence interval: 0.94-0.99). The cumulative 12- to 18-month HIV-free survival probability was 0.95 (confidence interval: 0.91-0.97)...
Community-based therapy for multidrug-resistant tuberculosis in Lima, PeruCarole Mitnick
Program in Infectious Disease and Social Change, Department of Social Medicine, Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 348:119-28. 2003..We evaluated the results of community-based therapy for multidrug-resistant tuberculosis in a poor section of Lima, Peru...
Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in HaitiArachu Castro
Program in Infectious Disease and Social Change, Department of Social Medicine, Harvard Medical School, 641 Huntington Ave, Boston, MA 02115, USA
Am J Public Health 95:53-9. 2005..Rather than stigma, logistic and economic barriers determine who will access such services. Implications for scale-up of integrated AIDS prevention and care are explored...
Integrated HIV prevention and care strengthens primary health care: lessons from rural HaitiDavid A Walton
Division of Social Medicine and Health Inequalities, Brigham and Women s Hospital Partners In Health, Boston, Massachusetts 02115, USA
J Public Health Policy 25:137-58. 2004..We conclude that improving AIDS prevention and treatment can help to reinvigorate flagging efforts to promote universal primary health care...
Whither equity in health? The state of the poor in Latin AmericaPaul Farmer
Department of Social Medicine, Harvard Medical School, Boston, MA, USA
Cad Saude Publica 23:S7-12. 2007
Expansion of cancer care and control in countries of low and middle income: a call to actionPaul Farmer
Harvard Medical School, Boston, MA, USA
Lancet 376:1186-93. 2010....
New malaise: bioethics and human rights in the global eraPaul Farmer
Brigham and Woman's Hospital, Division of Infectious Disease, Boston, Massachusetts, USA
J Law Med Ethics 32:243-51, 190-1. 2004..Here we call for a new focus on equity and human rights in bioethics...
Political violence and public health in HaitiPaul Farmer
Clinique Bon Sauveur, Cange, Haiti
N Engl J Med 350:1483-6. 2004
Limited good and limited vision: multidrug-resistant tuberculosis and global health policyJim Yong Kim
Harvard Medical School, 641, Huntington Avenue, Boston, MA 02115, USA
Soc Sci Med 61:847-59. 2005....
Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experienceSonya Shin
Division of Social Medicine and Health Inequalities, Brigham and Women s Hospital, 1620 Tremont St 3rd Floor, Boston, MA 02120 1613, USA
Soc Sci Med 59:1529-39. 2004..We describe the first such program and highlight the crucial components and most critical challenges to creating a successful community-based MDR-TB treatment program...
Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort studySalmaan Keshavjee
Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA
Lancet 372:1403-9. 2008..Mycobacterium tuberculosis strains that cause untreatable drug-resistant disease are a threat worldwide. We describe the treatment, management, and outcomes of patients with extensively drug-resistant tuberculosis in Tomsk, Russia...
Partners in pathology: a collaborative model to bring pathology to resource poor settingsJoseph W Carlson
Department of Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
Am J Surg Pathol 34:118-23. 2010....
Partners: discernment and humanitarian efforts in settings of violenceNicole Gastineau Campos
Brigham and Women's Hospital, Boston, Massachusetts, Division of Infectious Disease, USA
J Law Med Ethics 31:506-15. 2003
Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherenceJoia S Mukherjee
Division of Social Medicine and Health Inequalities, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
J Acquir Immune Defic Syndr 43:S123-6. 2006..In addition, the neediest patients receive nutritional support. Following the description of the program is an approximation of the costs of these interventions and a discussion of their impact...
Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 casesSonya Shin
Program in Infectious Disease and Social Change, Department of Social Medicine, Harvard Medical School, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Clin Infect Dis 36:996-1003. 2003..In each of these 7 cases, excellent treatment outcomes were obtained for the women and their children. Under certain circumstances, MDR-TB can be successfully treated during pregnancy...
Obstructed labor and caesarean delivery: the cost and benefit of surgical interventionBlake C Alkire
Department of Otology and Laryngology, Harvard Medical School, Boston, Massachusetts, United States of America
PLoS ONE 7:e34595. 2012....
Programmes and principles in treatment of multidrug-resistant tuberculosisJoia S Mukherjee
Brigham and Women s Hospital, Division of Social Medicine and Health Inequalities, Boston, MA, USA
Lancet 363:474-81. 2004..As treatment of MDR-TB becomes increasingly available in resource-poor areas, where it is needed most, further clinical and operational research is urgently needed to guide clinicians in the management of this disease...
Rethinking health and human rights: time for a paradigm shiftPaul Farmer
Harvard Medical School, Boston, USA
J Law Med Ethics 30:655-66. 2002
Tungiasis in rural Haiti: a community-based responseJ Keith Joseph
Division of Social Medicine and Health Inequalities, Brigham and Women s Hospital, 1620 Tremont Street, 3rd Floor, Boston, MA 02120, USA
Trans R Soc Trop Med Hyg 100:970-4. 2006..All superinfections were resolved. We concluded that community-based care can treat tungiasis effectively...
Casualties: narrative and images of the war on IraqSeiji Yamada
University of Hawaii John A Burns School of Medicine, Honolulu, HI 96813 5534, USA
Int J Health Serv 36:401-15. 2006..The suffering of the people of Iraq should spur a response from the health community to alleviate the situation and prevent unnecessary suffering...
The pricing and procurement of antiretroviral drugs: an observational study of data from the Global FundAshwin Vasan
Department of HIV AIDS, World Health Organization, Geneva, Switzerland
Bull World Health Organ 84:393-8. 2006..The price of ARVs has considerable implications for the sustainability of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) treatment in the developing world...
International electives: maximizing the opportunity to learn and contributeRajesh Gupta
Stanford University School of Medicine, Palo Alto, California, USA
MedGenMed 7:78. 2005
Directly observed therapy for HIV antiretroviral therapy in an urban US settingHeidi L Behforouz
J Acquir Immune Defic Syndr 36:642-5. 2004
